ICD-10-CM Billable Code

D48.118

Desmoid tumor of other site

Clinical Classification Guidelines

Medical Intelligence & Overview

A desmoid tumor, also known as aggressive fibromatosis, is a rare type of growth that develops from connective tissue, primarily benign but locally aggressive. When classified under ICD-10 as D48.118, it indicates a desmoid tumor located in an area other than the common sites such as the abdomen or limbs. Despite being non-cancerous, these tumors can cause significant health issues due to their invasive nature and tendency to recur after treatment.

Causes & Symptoms

Clinical Causes: Genetic factors, such as mutations in the APC gene or beta-catenin gene, can increase susceptibility. History of familial adenomatous polyposis (FAP), a hereditary condition, is linked to an increased risk. Previous trauma or surgical scars may occasionally be associated with desmoid tumors. Hormonal influences, particularly estrogen, might play a role in some cases, especially in women of reproductive age.

Key Symptoms: A noticeable lump or mass that gradually enlarges over time. Localized pain or tenderness around the affected area. Swelling that might cause discomfort or restrict movement. In some instances, the tumor might press on surrounding tissues or nerves, leading to functional impairments.

Diagnostic & Treatment

Diagnosis Path: Physical examination to identify the presence and characteristics of the lump. Imaging tests like MRI, CT scans, or ultrasound to determine the size, location, and extent of the tumor. Biopsy, often performed with a needle or surgical removal, to confirm the diagnosis by examining tissue samples under a microscope. Genetic testing in patients with a family history of related conditions.

Treatment Protocols: Surgical removal of the tumor is a common approach, aiming for complete excision with clear margins. Radiation therapy may be considered for unresectable tumors or as an adjunct to surgery. Systemic treatments like hormonal therapy, including anti-estrogen medications, might be utilized in some cases. Chemotherapy or targeted therapies are options for tumors that are difficult to treat surgically or recur frequently. Observation or active surveillance could be suitable for slow-growing or asymptomatic tumors under certain circumstances.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D48.118 a billable ICD-10 code?
Yes, D48.118 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D48.118?
Clinical documentation must specify the nature of Desmoid tumor of other site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference